Short title: TBX1 controls cell-ECM interaction 2 SUMMARY Tbx1, the major candidate gene for DiGeorge or 22q11.2 deletion syndrome, is required for efficient incorporation of cardiac progenitors (CPs) of the second heart field (SHF) into the heart. However, the mechanisms by which TBX1 regulates this process are still unclear. Here, we have used two independent models, mouse embryos and cultured cells, to define the role of TBX1 in establishing morphological and dynamic characteristics of SHF in the mouse. We found that loss of TBX1 impairs extra cellular matrix (ECM)-integrin-focal adhesion (FA) signaling in both models. Mosaic analysis in embryos showed that this function is non-cell autonomous and, in cultured cells, loss of TBX1 impairs cell migration and focal adhesions. Additionally, we found that ECM-mediated outside-in integrin signaling is disrupted upon loss of TBX1. Finally, we show that interfering with the ECM-integrin-FA axis between E8.5 and E9.5 in mouse embryos, corresponding to the time window within which TBX1 is required in the SHF, causes outflow tract dysmorphogenesis. Our results demonstrate that TBX1 is required to maintain the integrity of ECM-cell interactions in the SHF, and that this interaction is critical for cardiac outflow tract development. More broadly, our data identifies a novel TBX1 downstream pathway as an important player in SHF tissue architecture and cardiac morphogenesis.
INTRODUCTION
The heart develops from populations of progenitor cells that are specified as early as gastrulation. In vivo labeling and genetic clonal analyses have identified at least two distinct populations, the first (FHF) and second (SHF) heart fields (1) (2) (3) (4) (5) . These lineages derive from cells that independently activate Mesp1 in the primitive streak and differentiate sequentially during cardiogenesis to give rise to distinct parts of the heart (6, 7). The SHF is part of a mesodermal population that gives rise to cardiomyocytes as well as other cell types, including branchiomeric skeletal muscles and some populations of endothelial cells. Overall, this multipotent cell population is referred to as the cardiopharyngeal mesoderm (CPM) lineage (8) .
CPM/SHF progenitors migrate as part of the splanchnic pharyngeal mesoderm and undergo progressive differentiation to give rise to myocardium at the cardiac poles. Defective deployment of SHF cells results in a spectrum of common forms of congenital heart defects (CHD). The cellular and molecular genetic mechanisms by which progenitor cells are directed and sorted into the different cell types and regionalized in the pharyngeal apparatus towards the cardiac poles are only now beginning to emerge (9) . Specifically, SHF progenitors destined to contribute to the arterial and venous poles of the heart are organized into an epithelial-like layer of cells, between embryonic day (E) 8 and E9.5, that forms the dorsal pericardial wall (DPW). The epithelial properties of the SHF are emerging as a critical regulatory step during the process of heart tube elongation, yet how regulators of SHF deployment impact on SHF cell biology remains poorly understood (10) . Tbx1 has been shown to be required for progenitor recruitment to the heart (11, 12) and its loss has been associated with disruption of epithelial polarity in the DPW (13) , and reduced tension of the epithelial sheet (14) , although the mechanisms by which these phenotypic anomalies occur remain unclear. Planar cell polarity (PCP) genes Dvl2 and Wnt5a have been proposed to be part of this process by facilitating the incorporation, by intercalation, of mesenchymal cells into the epithelial sheet of the DPW (15) (16) (17) . TBX1 regulates Wnt5a expression in the SHF (18) , suggesting that at least some of the tissue architectural roles of TBX1 may operate through the non-canonical WNT/PCP pathways. However, Wnt5a -/-;Tbx1 -/-embryos have much more severe SHF-derived heart defects than the individual mutants, providing genetic evidence that the two genes also have non-overlapping functions in the SHF (18) .
Here, we use two independent models, mouse embryos and cultured cells, to show that Tbx1 regulates the extra cellular matrix-integrin-focal adhesion axis and alters the properties of splanchnic mesoderm, both in epithelial cells of the DPW and in the adjacent mesenchyme. We demonstrate that the epithelial layer of the SHF has an apical adhesion domain that includes immunoreactivity for E-cadherin, beta-catenin, paxillin, and actomyosin, and this domain is disrupted in Tbx1 -/-embryos. Moreover, our results indicate that TBX1 is required to sustain ECM-intracellular signaling and that integrin-focal adhesion integrity is critical for cardiac outflow tract development. These findings identify TBX1 regulation of the ECMfocal adhesion axis as a critical component of early heart morphogenesis and candidate pathway in the etiology of congenital heart defects.
RESULTS
The ECM-Integrin-FA axis is altered in the SHF of Tbx1 mutants.
Despite evidence for the importance of the epithelial features of SHF cells in the DPW, how these properties are regulated is unclear. In particular how the ECM and cell adhesion are coordinated during SHF deployment has not been studied. We set out to test a group of markers critical for cell dynamics in the SpM of WT and Tbx1 mutant embryos; specifically, we investigated markers of the extracellular matrix (ECM), integrin, and focal adhesion. At E9.5 COLI, the most abundant fibrillar collagen (encoded by the Col1a1 gene), was expressed in the SpM, laterally and posteriorly to the pericardial cavity (Fig. 1A) . COL1 also accumulates in the mesenchymal tissue adjacent and abutting to the basal side of the epithelial-like layer of the SHF (eSHF), where it formed a rudimentary and discontinuous basal lamina, but was not observed laterally or apically to the eSHF cells (Fig. 1C) . In Tbx1 -/-embryos, COLI immunostaining was increased in the SpM and we noted a broader and mislocalized distribution in the eSHF where the collagen fibrils were randomly distributed around the cells, rather than being restricted to a basal lamina (Fig. 1B, D and Supplementary  Fig. 1-2) .
ITGB1, the β1 integrin subunit, was expressed in the anterior SHF (here defined as the anterior half of the DPW, close to the arterial pole of the heart), but not in the posterior SHF (Fig. 1E) . ITGB1 was principally localized at cell-cell contacts and at the basal side of eSHF cells ( Fig. 1E and Supplementary Fig. 2 ), and to a lesser extent at the apical region.
ITGB1 was decreased in Tbx1
-/-embryos compared to WT embryos ( Fig. 1F and Supplementary Fig. 2 ).
Considering that transduction of integrin signaling is associated with focal adhesions, we used IF with an antibody for the FA marker Paxillin (PXN) and found that it is expressed in the SHF and is predominantly localized in the apical and, to a lesser extent, the basal side of cells in the eSHF (Fig. 2A) . A similar apical and basal distribution of PXN was also visible in other epithelia, such as the pharyngeal endoderm ( Fig. 2A) . In the eSHF, we found that apical PXN staining partially overlapped with cell-cell adhesion complex proteins E-cadherin (CDH1) and beta-catenin (CTNNB1) (Fig. 3A-H and Supplementary Movie 1, Supplementary Movie 2). Specifically, the immunostaining overlap was observed in the apical-lateral region of eSHF cells, at the level of cell-cell junctions (Fig. 3A-H) , where tight and adherens junction proteins accumulate. In the eSHF we observed a similar pattern with another FA protein, Vinculin (VCL, Fig. 2C ). PXN expression in Tbx1 -/-embryos was reduced and, strikingly, its apical-lateral distribution could not be detected (Fig. 2B) . Likewise, VCL was also reduced (Fig. 2D) . Moreover, CDH1 was reduced in Tbx1 -/-mutants, especially in posterior-lateral regions of the DPW (Fig. 2E-F) . Cortical actin staining was also reduced in Tbx1 -/-mutants ( Supplementary Fig. 3A-B) , suggesting impaired assembly of junctional Factin networks. The actin-motor non-muscle myosin IIB (NMIIB, a.k.a. MYH10) regulates both actin rearrangements and FAs formation and is required for OFT morphogenesis (19) (20) (21) . We found that NMIIB predominantly decorates the apical side and, to a lesser extent, the lateral side of eSHF cells, while in Tbx1 -/-embryos, this specific localization was lost and the protein was randomly distributed around the eSHF cells ( Supplementary Fig. 3C-D) . The altered distribution of NMIIB reinforces the idea that TBX1 supports the ability of the eSHF to undergo morphogenetic changes, acquiring epithelial features which are essential for proper heart morphogenesis (13, 14) .
ECM-and cell-cell interactions are critical for cell orientation and apico-basal polarization. Considering that cellular elements like the centrosome or the Golgi apparatus are polarised in epithelial cells, we used Giantin, a Golgi marker, to assay apicobasal polarity of eSHF cells. In WT embryos, the Golgi apparatus of most eSHF cells (~80%) is apically positioned (Supplementary Fig. 3E-G) , whereas in Tbx1 -/-embryos approximately only ~60% of cells presented an apical localisation (Supplementary Fig. 3E-G ). This polarization defect was observed predominantly in the anterior eSHF ( Supplementary Fig. 3G ). Overall, these findings identify novel features of the eSHF and Tbx1 null epithelial phenotype and show that loss of function of Tbx1 causes a multifaceted cell phenotype related to impaired ECM-cell interactions.
Cell non-autonomous functions of TBX1 in the SHF.
We reasoned that if loss of Tbx1 alters the overall tissue organization by altering ECM-cell interactions, the deletion of Tbx1 in a small number of cells within the tissue should be insufficient to alter the tissue architecture. To test this, we used E9. 4A -B and Supplementary Fig. 4E ). Furthermore, CDH1 distribution appeared homogeneous between GFP+ and surrounding cells ( Supplementary Fig. 4C -D and Supplementary Fig. 4F ). These findings indicate that the anomalous distribution of NMIIB or the alteration of CDH1 levels are not cell-autonomous phenotypes, suggesting that they are secondary to ECM disorganization and/or that there is a rescue-by-neighbors effect.
Tbx1 regulates cell migration, polarization, and adhesion in cultured cells.
To address the role of TBX1 on cell dynamics, we decided to use cell culture models that allow for manipulation of the FA-integrin pathway. To understand whether TBX1 is involved in cell movements, we first performed a generic cell migration assay in a chemotactic gradient of serum. For this, we used two independent cell lines that express Tbx1: C2C12 undifferentiated myoblast cells and primary mouse embryonic fibroblasts (MEFs). For C2C12 cells, we used RNA interference to knock down (KD) Tbx1 expression, while MEFs were obtained from WT, Tbx1 +/-and Tbx1 -/-embryos. Results showed that cell migration was significantly reduced following either TBX1 dosage reduction or KD (Fig. 4A-B and Supplementary Fig. 5A ). We also used a two dimensional assay based on closure of mechanically inflicted wounds in confluent cell monolayers, monitored by time-lapse microscopy for 24 hrs. Tbx1 depletion reduced C2C12 cell migration into the wound area (Fig. 4C) ; this effect was not due to differences in cell proliferation because we did not find a significant change in cell proliferation in the time window within which the migration assay was performed ( Supplementary Fig. 5B ). Furthermore, we found that migrating Tbx1-depleted (Tbx1 KD ) cells plated on COLI failed to polarize properly, as they exhibited aberrant repositioning of the Golgi apparatus (Fig. 4D) , consistent with in vivo data. The number of polarized cells was reduced by 80% in Tbx1 KD cells compared with control cells (Supplementary Fig. 5C ). Phalloidin staining revealed that control cells formed lamellipodia at the edge of the wound but Tbx1 KD cells showed fewer lamellipodial protrusions ( Fig. 4D and Supplementary Fig.6A -E), indicating that TBX1 is required for the formation of these structures, which produce the driving force for migration. Moreover, IF analysis showed that in control cells alpha-tubulin is enriched at the leading edge, while in Tbx1 KD cells the microtubule distribution is more uniform around the cells ( Supplementary Fig. 5D -E and Supplementary Fig. 6B -E confirming a polarization defect.
The migration impairment might be due to defective interactions with the substrate (22) . The cell spreading assay in tissue culture is useful to test cell adhesion defects and, in particular, defects regarding the formation and disassembly of initial adhesive cell contacts. C2C12 cells were plated on a variety of substrates, specifically COLI, Fibronectin (FN), Matrigel, or uncoated plastic. We then evaluated cell spread area after 20 min in culture. We found that Tbx1 KD C2C12 cells had a significantly reduced spread area and perimeter compared to non-target (NT) siRNA-treated control cells on all substrates, except FN (Fig.  4E) . Tbx1 KD cells appeared rounded and less spread compared to control cells (Fig. 4F) . Tbx1 depletion did not alter significantly the size of cells in suspension (Supplementary Fig. 5F ). Furthermore, we found that, consistent with in vivo data, the expression of integrin Itgb1 was decreased in Tbx1 KD cells (Fig. 4G ) and ITGB1 was reduced in both the membrane surface and in FAs, as shown by flow cytometry and IF, respectively ( Fig. 4H and Supplementary  Fig. 5G-H) . In addition, Tbx1 KD cells showed a significant increase of aberrant protrusions ( Supplementary Fig. 5I-M) , a phenotype previously shown to be associated with loss of Focal Adhesion Kinase (FAK) or PXN (23, 24) . Indeed, PXN, which is a major adapter protein of FAs, was down regulated at both mRNA and protein levels in Tbx1 KD cells (Fig. 5A ). Given these results, we tested for possible FA abnormalities. We analyzed control and KD cells, the VCL staining was predominantly restricted to shorter plaques and we rarely observed elongated FAs (Fig. 5B , lower panels). Quantitative analysis of VCL IF confirmed that the number and size of FAs were reduced in Tbx1 KD compared to control cells (Fig. 5C , lower panels).
Overall these findings reveal that TBX1 regulates ECM-integrin-FA signaling and that loss of function of TBX1 has major functional consequences for cell migration and spreading.
TBX1 is a positive regulator of ECM-mediated signaling.
The concomitant alteration of ECM, integrin, and FA protein expression and/or distribution in Tbx1 mutant embryos suggests that TBX1 may regulate ECM-cell signaling. Integrins can signal through the cell membrane in either direction: the extracellular binding activity of integrins is regulated from the inside of the cell (inside-out signalling), while the binding of the ECM elicits signals that are transmitted into the cell (outside-in signalling) (25, 26) . To determine the consequences of Tbx1 silencing on outside-in signalling, we analyzed the activation of integrin-stimulated signalling cascades in C2C12 cells following adhesion to ECM proteins COLI and FN. In particular, we tested the principal components of PXNmediated ECM-dependent signalling: FAK, extracellular-signal regulated kinases (ERK1/2), and Cofilin1 (CFL1). CFL1 is a critical cortical actin regulator, which severs actin filaments to increase the number of sites for actin polymerization in lamellipodia and is inhibited by adhesion signalling (including PXN-signalling) through phosphorylation of Ser3 (27) . ECM engagement induced phosphorylation of FAK, ERK1/2, and CFL1 ( Fig. 6A-B and Supplementary Fig. 6F ) in control cells plated on COLI or FN for 30 min. In Tbx1 KD cells, the phosphorylation of PXN (Tyr118), FAK (Tyr397 and Tyr925), CFL1 (Ser3) and ERK1/2 were all strongly reduced ( Fig. 6A-B) . Consistent with this result, P-ERK expression has been shown to be reduced in the eSHF of Tbx1 -/-embryos (15) . The defect of signalling cascade activation was only evident in ECM-plated Tbx1 KD cells ( Supplementary Fig. 6G ). These results indicate that loss of TBX1 affects at least two different aspects of ECM signalling: actin dynamics (CFL1) and cell adhesion (FAK, PXN, ERK).
The integrity of the ECM-integrin-FA axis is required for OFT morphogenesis.
To test whether interference with the ECM-integrin-FA axis between E8.5 and E9.5 (the critical time window for TBX1 function in the SHF) has consequences for OFT morphogenesis, we used chemical inhibitors in an embryo culture model (28). To this end, we used the disintegrin Echistatin (a potent integrin inhibitor), and a more specific inhibitor 6-B345TTQ, which blocks the alpha4 integrin-PXN interaction (29, 30). E8.5 WT embryos were cultured for 20 hours in the presence of inhibitor or vehicle (control) and OFT length and morphology were evaluated. Both inhibitors caused a significant reduction of OFT length compared to control embryos ( Fig. 7G and Supplementary Fig. 7C ). Additionally, histological analyses and N-Cadherin immunofluorescence of cultured embryos indicated that despite OFT dysmorphogenesis, epithelial integrity was not compromised (Fig. 7D-F ).
DISCUSSION
Tbx1 is required for cardiac progenitor cell contribution to the arterial and venous poles of the heart in mouse embryos, and is a major candidate gene for 22q11.2 deletion syndrome, which is often associated with congenital heart disease. In this work, we show that TBX1 is a regulator of the ECM-integrin-FA-intracellular signalling axis in SHF cells of the SpM of mouse embryos, and that loss of TBX1 has disruptive consequences on tissue architecture and heart development. The ECM-integrin-FA axis is central for cell migration, adhesion and polarity, and we show that in an embryo culture model, inhibition of integrin-FA interactions in a specific time window is associated with OFT dysmorphogenesis. Together our results indicate that abnormalities of ECM-integrin-FA signaling are likely to contribute to the OFT defects caused by loss of TBX1, providing new mechanistic insights into the origin of congenital heart defects.
Tbx1 is expressed in SpM in both the epithelial layer and adjacent mesenchyme. Previous reports have hypothesized a process of intercalation as a means of mesenchymal cells to contribute to the epithelial layer (15) (16) (17) . However, this model still needs to be confirmed. Given the continuity of gene expression of several SHF markers in the mesenchyme and epithelial layer, and the discontinuity of the basal membrane, it is possible that mesenchymal cells contribute to the epithelial layer through a process akin to condensation. This process is mediated by cadherin in a manner that is mechanistically analogous to integrin-mediated spreading on ECM (31). Live imaging will address the cell dynamics of eSHF expansion and putative contribution from the underlying mesenchyme.
We have characterized novel features of the epithelial properties of the SHF and how dysregulation causes defects at both the cellular and tissue-wide levels. In particular we found that FA proteins PXN and VCL are localized at the apical and basal sides of the DPW/eSHF. The basal localization is consistent with typical FA functions in the interaction between ECM-integrin-FA-cytoskeleton components. However, the apical localization and its extensive overlap with E-cadherin and beta-catenin are consistent with association with actin cytoskeleton at epithelial junctions or cell-cell junctions, similar to what has been described in other epithelia (23) , (32-42). The finding that ITGB1 mostly accumulates at cell-cell contacts in the eSHF suggests the existence of a functional interaction between integrin-and cadherinmediated cell adhesion complexes. This adhesion complex might represent an anchor point for mesenchymal cells in the eSHF either during initial mesenchymal condensation and/or during deployment of SHF cells to the cardiac poles.
At the apical/lateral region of the eSHF we also found a contractile protein, NMIIB/MYH10, a non-muscle myosin that maintains cortical tension and cell shape, and is required for heart development (19, 21, 43, 44) , although its specific role in the SHF has not been determined. The consequences of NMIIB mislocalization caused by loss of TBX1 are still unclear, but recent data has shown that disruption of the actomyosin machinery using a ROCK inhibitor changes cells shape but does not seem to affect epithelial tension in the SHF, consistent with a role for actomyosin in preventing cell distortion in the SHF in response to epithelial tension rather than regulating tension itself (14) .
Our in vivo mosaic data indicate that at least some of the TBX1 functions in the SHF are non-cell autonomous, consistent with previously reported chimera analyses showing that individual Tbx1
-/-cells in a WT background are able to contribute to the OFT (11). These findings suggest a critical contribution of the ECM to the pathogenesis of phenotypic abnormalities and predict that these abnormalities may arise only if there is a critical number of mutant SHF cells. The crucial role of ECM-cell interaction in OFT development is supported by the OFT shortening observed following our integrin-FA blocking experiments. While integrin signaling has been shown to be essential for heart development (45-49), our data specifically implicate the SHF as a target cell type of integrin signaling during this process and identify a critical time window during which integrin-PXN interaction is required for OFT extension.
The identification of transcriptional targets of TBX1 provides mechanistic insight as to how this transcription factor may drive the processes described here. Indeed, ChIP-seq and RNA-seq data indicate that focal adhesion (including the Pxn gene), ECM-receptor and MAPK signaling are among the top-scoring pathways affected by reduced dosage of the Tbx1 gene (50). Several of these pathways have been implicated in heart development. For example, conditional deletion of the FAK-encoding gene in the Nkx2-5 expression domain is sufficient to cause OFT defects in mouse embryos (51). However, their upstream regulators during cardiac development have not yet been fully determined and it is likely that TBX1 regulates the ECM-integrin-FA axis by hitting multiple targets.
Overall, our data indicate that TBX1 impacts on cell dynamics and regulates ECMintracellular signaling at different levels. In particular, we found that in the eSHF, PXN, VCL, E-cadherin, F-actin and NMIIB are localized at the apical-lateral region of the monolayer of cells, possibly assembling an actomyosin apparatus that provides, through cortical signaling, cohesiveness among the epithelial-like cells. The localization of most of these proteins and the polarity of eSHF cells is severely altered in mutant embryos, thus compromising the cohesiveness of the epithelial cell layer and providing a mechanistical basis for the previously observed cell roundness and protrusion phenotype (13) . In addition, these polarity and cohesiveness defects could also explain the loss of tension within the SHF (14) and the reduced contribution of SHF cells to the heart in these mutants. Our results thus reinforce and extend the emerging paradigm that regulation of the epithelial properties of cardiac progenitor cells in the SHF is a critical step in early heart morphogenesis. Moreover, they provide new insights into how SHF regulators such as TBX1 may impact on progenitor cells properties including proliferation and differentiation through the control of ECM-cell interactions and tissue architecture.
EXPERIMENTAL PROCEDURES

Mouse lines
The 
Cell culture and transfections
Mouse C2C12 undifferentiated myoblast cells obtained from the ATCC (catalog CRL-1772) were cultured in Dulbecco's modified Eagle's medium (DMEM, Invitrogen) supplemented with 10% FBS and L-glutamine (300 μg/ml), and were free of mycoplasma. Primary mouse embryonic fibroblasts (MEFs) were isolated from Tbx1 +/− , Tbx1 -/-, and wildtype embryos at E13.5. To this end, the internal organs, head, tail and limbs were removed. Cells were cultured in Dulbecco's modified Eagle's medium with 20% FBS and 1% NEAA, and used for a maximum of 3 passages. Cells were incubated at 37°C in 5% CO 2 . For siRNA transfection, cells were seeded at 1.2×10 5 per well in six-well plates and transfected with a pool of Silencer Select Pre-Designed Tbx1 SiRNA (Life Technology) (final concentration 50 nmol/L) in antibiotic-free medium using Lipofectamine RNAiMAX Reagent (Life Technology) according to the manufacturer's instructions. 48hrs after siRNA transfection, cells were collected and processed for further analysis.
Immunoblotting
Cells were harvested in lysis buffer (50 mmol/L Tris-HCl pH 7.6, 2 mmol/L EDTA, 150 mmol/L NaCl, 0.5% Triton X-100) supplemented with 1 mM phenylmethylsulphonyl fluoride and 1× complete mini EDTA-free protease inhibitor and PhosSTOP phosphatase inhibitor (Roche). Debris was removed by centrifugation at 10,000 g for 20 min at 4°C, and protein content was assessed by a Bradford protein assay. Nuclear proteins were extracted as described previously (23) . Proteins were separated by SDS-PAGE and transferred to Immobilon-P PVDF membranes (Biorad). Membranes were subsequently incubated for 1 hour at room temperature in TBST buffer [125 mmol/L Tris-HCl (pH 8.0), 625 mmol/L NaCl, 0.1% Tween 20] containing 5% BSA and further incubated at 4°C for 16 hours with primary antibodies (listed in Table 1 ). Secondary HRP-conjugated mouse and rabbit (GE Healthcare) or rat (Dako) antibodies were used at a dilution of 1:5000. Membranes were developed using the enhanced chemiluminescence system (GE Healthcare). X-ray films were scanned and processed using ImageJ software for densitometric analysis.
Migration assay
Transwell filters coated with 0.1% gelatin (diluted in PBS) with a PET membrane with 8 μm pores (BD Biosciences) were rehydrated for 2 hrs at 37°C in medium without supplements. Transfected cells were washed once in PBS, and 10 5 cells were seeded into the upper chamber of the Transwells in serum-free medium containing 0.1% BSA. Medium containing 10% FBS or 0.1% BSA was added to the bottom chamber as a chemoattractant. Control wells without FBS were included to assess random migration. Cells were allowed to migrate for 4 hrs at 37°C, in 5% CO 2 . The cells on the bottom part of the membrane were fixed in methanol containing 0.1% Crystal Violet. Ten separate bright-field images were randomly acquired of each Transwell filter using a Leica DMI6000 microscope with a Plan APO 10×objective (Leica Microsystems). The cells in each image were counted and analyzed in comparison with control-transfected cells. Migration in the absence of FBS (random migration) was taken as 100% for each siRNA treatment, to control for variations in final cell number. For scratch wound assays cells were seeded 24 hrs after transfection in 24-well plates at confluency in growth medium; the confluent monolayer was wounded after 24 hrs by scraping with a pipette tip and then imaged by time-lapse microscopy. A phase-contrast image was acquired every 10 minutes for 18 hrs on a fully motorized Leica DMI6000 microscope with a Plan APO 10× objective. The area occupied by cells in scratch wounds was determined from time-lapse movie images taken at different time after wounding, using ImageJ analysis software. For polarity analysis, cells were plated at confluency on coverslip coated with Collagen I, wounded and fixed 4-6 hrs after wounding for anti-giantin immunostaining.
Cell adhesion and spreading
Flat-bottom 96-well microtiter plates were coated with 10 µg/ml Collagen I (SigmaAldrich), 5 µg/ml Fibronectin (Roche), 100 μg/ml Matrigel (BD Biosciences) or 1% heatdenatured BSA in PBS (uncoated plastic) as a negative control, and incubated overnight at 4°C. Plates were then blocked for 1 hour at room temperature with 1% heat-denatured BSA in PBS. Cells were harvested using trypsin and allowed to recover for 1 hr. at 37°C, then washed three times in PBS. 10 5 cells were plated in each coated well and incubated for 1 hr. at 37°C. Then, culture plates were washed with phosphate-buffered saline (PBS). Attached cells were fixed with 4% paraformaldehyde in PBS for 10 minutes. Cells were finally stained with 0.5% Crystal Violet in 20% methanol. The stain was eluted using 0.1 M sodium citrate in 50% ethanol, pH 4.2, and the absorbance at 595 nm was measured in a spectrophotometer. Alternatively, cells were fixed with 4% paraformaldehyde and counted under the microscope to corroborate the plate reader results. For cell spread area measurements, cells were allowed to spread on the indicated substrates for 20 min and fixed with paraformaldehyde without washing. Cells were then stained for F-actin, and area and perimeter quantified with ImageJ software.
Flow Cytometry analysis
For analysis of surface-β1 integrin levels, cells were scraped into PBS, fixed in 4% PFA-PBS for 30 min on ice and fixed with 4% paraformaldehyde; then cells were blocked in 5% BSA-PBS for 30 min on ice. Cells were then incubated with 10 μg/ml anti-integrin β1 for 1 hr. on ice. Purified immunoglobulin was used as a negative control. The cells were then washed and incubated with a fluorescein isothiocyanate-labelled goat anti-rat IgG for 30 min at 4°C. Finally, the cells were washed and analyzed by flow cytometry using a FACSCanto (Becton Dickinson).
Immunofluorescence and confocal microscopy
Cells were fixed with 4% paraformaldehyde, permeabilized with 0.2% Triton X-100 in PBS, and blocked with 1% BSA in PBS. After incubation with primary antibodies (listed in Table 2 ), cells were incubated (1hr, RT) with the appropriate secondary antibodies (Alexa Fluor 488, 594; 1:400; Molecular Probes) and, when indicated, with Alexa fluor phalloidin (wavelength 480 nm; Invitrogen) for F-actin visualization; DAPI was used for nuclear staining. Confocal images were acquired with an inverted confocal microscope (Nikon A1) using 63× (1.4 NA) objective lenses. Images were from cells fixed 48 hrs after transfection unless indicated differently.
FAs size analysis
A pipeline of Cell Profiler software (53) was used to quantify focal adhesions/complexes (number and size) from images of cells stained with anti-Paxillin, antiphospho-Paxillin or anti-vinculin antibodies. Cells were either serum starved and stimulated to spread onto ECM-coated coverslips or grown in medium containing 10% FBS on glass coverslips. More than 100 FAs from two different experiments were analyzed.
Histology and Immunofluorescence
E9.5 (23-25 somites) mouse embryos were fixed in 4% PFA and embedded in OCT. 10µm sagittal or transverse cryosections and subjected to immunofluorescence using primary antibodies listed in Table 2 ), and secondary antibodies Alexa fluor 488 (or 594 or 647) Goat anti-rabbit (or anti-mouse or anti-rat) IgG (H+L) (Life Technologies, 1:400). Alternatively, embryos were embedded in paraffin and then sectioned for immunostaining. Immunofluorescence experiments were imaged using a NIKON A1 confocal microscope or a Zeiss LSM 780 confocal microscope. We tested at least 3 embryos per antibody per genotype.
Embryo culture
Embryo culture was performed as previously described (28). Embryos were cultured for 20 hours from E8.5 (7-11 somites). Control embryos were cultured with DMSO and treated embryos were cultured with either 50μM 6-B345TTQ (B7438, Sigma-Aldrich), a specific inhibitor of paxillin-integrinα4 interaction or with 2.5μg/ml of Echistatin (E1518, SigmaAldrich), a potent disintegrin.
Measurements and quantifications of OFT
Right lateral views of whole embryos were used to measure OFT length using ImageJ. Number of embryos per condition: 12 DMSO-cultured, 16 6-B345TTQ-cultured and 11 Echistatin-cultured embryos. Data are presented as mean±s.e.m. P values were obtained using a bilateral Mann-Whitney test.
RNA extraction, cDNA synthesis, and quantitative RT-PCR
RNA was extracted from C2C12 cells using TRI-Reagent (Ambion/Applied Biosystems) according to the manufacturer's protocol. Extracted RNA was treated with DNAfree Kit (Ambion/Applied Biosystems). cDNA was synthesized from 1 µg total RNA (normalized via UV spectroscopy) using the High Capacity cDNA Reverse Transcription Kit, according to the manufacturer's instructions (Applied Biosystems). Target cDNA levels were compared by Q-RT-PCR in 20-µl reactions containing 1× SYBR green (FastStart Universal SYBR Green Master (Rox), Roche), 0.2 µmol/L of each primer. Primers were as follows: for Tbx1 amplification, forward primer 5'-CTGACCAATAACCTGCTGGATGA-3' and reverse primer 5'-GGCTGATATCTGTGCATGGAGTT-3'; for Pxn amplification, forward primer 5'-GCTGCTGCTTCTGCTTCATC-3' and reverse primer 5'-GTGGGTCCTCATTGGTCTGG-3'; for Rpl13a amplification, forward primer 5'-CCCTCCACCCTATGACAAGA-3' and reverse primer 5'-CTGCCTGTTTCCGTAACCTC-3'. Results were normalized against Rpl13a and compared by relative expression and the delta-delta-cycle threshold method for fold change calculations with the StepOne v2.3 software (Applied Biosystems).
Statistical analysis
Statistical significance was determined by a two-tailed paired Student's t-test, unless otherwise specified. P-values <0.05 were considered as statistically significant. Error bars represent s.d.
Data availability
All the data used in this work are shown in the Figures and in the Supplementary information. All other data supporting the findings of this study are available from the corresponding authors on reasonable request. 
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